BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Lundbeck Inc. (LUN.CO) Given EU Nod for Alcohol Dependence Drug


2/28/2013 8:05:36 AM

Danish drugmaker Lundbeck has received European Union approval for Selincro, its innovative drug to fight alcohol dependency, a small boost in its fight against falling sales and heavy investment in new products. The EU decision, which follows a positive recommendation from the European Medicines Agency in December, will allow Lundbeck to launch the drug on the market in mid-2013, the company said on Thursday. "Lundbeck will provide Selincro as part of a novel treatment concept that includes continuous psychosocial support focused on the reduction of alcohol consumption," the company said. The drug has been developed as a one-a-day tablet to be taken as required on days when the patient feels he or she is at risk of drinking. Selincro, which blocks the action of opioid receptors in the brain, was licensed to Lundbeck from Finland's Biotie Therapies .

Read at Reuters

Reuters
   
Addiction

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES